1 |
Tamai, I. and Tsuji, A. (2000) Transporter-mediated permeation of drugs across the blood-brain barrier. J. Pharm. Sci. 89, 1371-1388.
DOI
ScienceOn
|
2 |
Theron, D., Barraud de Lagerie, S., Tardivel, S., Pélerin, H., Demeuse, P., Mercier, C., Mabondzo, A., Farinotti, R., Lacour, B., Roux, F. and Gimenez, F. (2003) Influence of tumor necrosis factor-alpha on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochem. Pharmacol. 66, 579-587.
DOI
|
3 |
Uceyler, N., Valenza, R., Stock, M., Schedel, R., Sprotte, G. and Sommer, C. (2006) Reduced levels of antiinfl ammatory cytokines in patients with chronic widespread pain. Arthritis. Rheum. 54, 2656-2664.
DOI
|
4 |
Walther, W. and Stein, U. (1994) Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J. Cancer Res. Clin. Oncol. 120, 471-478.
DOI
|
5 |
Yu, C., Kastin, A. J., Tu, H., Waters, S. and Pan, W. (2007) TNF activates P-glycoprotein in cerebral microvascular endothelial cells. Cell Physiol. Biochem. 20, 853-858.
DOI
|
6 |
Paludan, S. R. (2000) Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J. Leukoc. Biol. 67, 18-25.
|
7 |
Pardridge, W. M. (1988) Recent advances in blood-brain barrier transport. Annu. Rev. Pharmacol. Toxicol. 28, 25-39.
DOI
|
8 |
Perry, V. H., Anthony, D. C., Bolton, S. J. and Brown, H. C. (1997) The blood-brain barrier and the inflammatory response. Mol. Med. Today 3, 335-341.
DOI
ScienceOn
|
9 |
Poller, B., Drewe, J., Krahenbühl, S., Huwyler, J. and Gutmann, H. (2010) Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Cell. Mol. Neurobiol. 30, 63-70.
DOI
|
10 |
Puddu, P., Fais, S., Luciani, F., Gherardi, G., Dupuis, M. L., Romagnoli, G., Ramoni, C., Cianfriglia, M. and Gessani, S. (1999) Interferongamma up-regulates expression and activity of P-glycoprotein in human peripheral blood monocyte-derived macrophages. Lab. Invest. 79, 1299-1309.
|
11 |
Schinkel, A. H., Smit, J. J., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A., van der Valk, M. A., Robanus- Maandag, E. C., te Riele, H. P., Berns, A. J. M. and Borst, P. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
DOI
ScienceOn
|
12 |
Schmitz, H., Fromm, M., Bentzel, C. J., Scholz, P., Detjen, K., Mankertz, J., Bode, H., Epple, H. J., Riecken, E. O. and Schulzke, J. D. (1999) Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell Sci. 112, 137-146.
|
13 |
Spector, R. (1989) Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J. Neurochem. 53, 1667-1674.
DOI
|
14 |
Stins, M. F., Gilles, F. and Kim, K. S. (1997) Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 76, 81-90.
DOI
|
15 |
Hartz, A. M., Bauer, B., Fricker, G. and Miller, D. S. (2004) Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. Mol. Pharmacol. 66, 387-394.
DOI
|
16 |
Hartz, A. M., Bauer, B., Fricker, G. and Miller, D. S. (2006) Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Mol. Pharmacol. 69, 462-470.
|
17 |
Huber, J. D., Egleton, R. D. and Davis, T. P. (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24, 719-725.
DOI
ScienceOn
|
18 |
Konsman, J. P., Vigues, S., Mackerlova, L., Bristow, A. and Blomqvist, A. (2004) Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral infl ammatory stimuli. J. Comp. Neurol. 472, 113-129.
DOI
|
19 |
Kallmann, B. A., Hummel, V., Lindenlaub, T., Ruprecht, K., Toyka, K. V. and Rieckmann, P. (2000) Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1. Brain 123, 687-697.
DOI
|
20 |
Kipp, H., Pichetshote, N. and Arias, I. M. (2001) Transporters on demand: intrahepatic pools of canalicular ATP binding cassette transporters in rat liver. J. Biol. Chem. 276, 7218-7224.
DOI
|
21 |
McCarron, R. M., Wang, L., Racke, M. K., McFarlin, D. E. and Spatz, M. (1993) Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43, 23-30.
DOI
|
22 |
Ohmori, Y., Schreiber, R. D. and Hamilton, T. A. (1997) Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J. Biol. Chem. 272, 14899-14907.
DOI
ScienceOn
|
23 |
Akazawa, Y., Kawaguchi, H., Funahashi, M., Watanabe, Y., Yamaoka, K., Hashida, M. and Takakura, Y. (2002) Effect of interferons on P-glycoprotein-mediated rhodamine-123 efflux in cultured rat hepatocytes. J. Pharm. Sci. 91, 2110-2115.
DOI
|
24 |
Bauer, B., Hartz, A. M. and Miller, D. S. (2007) Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol. Pharmacol. 71, 667-675.
|
25 |
Dixit, S. G., Zingarelli, B., Buckley, D. J., Buckley, A. R. and Pauletti, G. M. (2005) Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}-stimulated human intestinal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G533-G540.
|
26 |
Belliard, A. M., Lacour, B., Farinotti, R. and Leroy, C. (2004) Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal Pglycoprotein expression, activity, and localization in Caco-2 cells. J. Pharm. Sci. 93, 1524-1536.
DOI
|
27 |
Cheshire, J. L. and Baldwin, A. S. Jr. (1997) Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaB-beta degradation. Mol. Cell Biol. 17, 6746-6754.
|
28 |
Cornford, E. M. (1985) The blood /brain barrier, a dynamic regulatory interface. Mol. Physiol. 7, 219-259.
|
29 |
Gijbels, K., Van Damme, J., Proost, P., Put, W., Carton, H. and Billiau, A. (1990) Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 20, 233-235.
DOI
|
30 |
Hao, X. R., Cao, D. L., Hu, Y. W., Li, X. X., Liu, X. H., Xiao, J., Liao, D. F., Xiang, J. and Tang, C. K. (2009) IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis 203, 417-428.
DOI
|